Skip to main content

Toronto Reports 523 Opioid Overdose Deaths Last Year

Toronto Reports 523 Opioid Overdose Deaths Last Year

Toronto Reports 523 Opioid Overdose Deaths Last Year, According to preliminary data from Toronto Public Health, there were 523 opioid toxicity deaths in the city in 2023, marking a 74% increase from 2019 when 301 deaths were recorded due to toxic drugs.  Of the 523 drug-related deaths in 2023, 427 have been classified as accidental. Almost half of these individuals were aged 25 to 44, with 54% living in private residences and 39% dying at home. The 2023 figures show a slight increase from 2022, which saw 51

Introduction

According to preliminary data from Toronto Public Health, there were 523 opioid toxicity deaths in the city in 2023, marking a 74% increase from 2019 when 301 deaths were recorded due to toxic drugs.

Of the 523 drug-related deaths in 2023, 427 have been classified as accidental. Almost half of these individuals were aged 25 to 44, with 54% living in private residences and 39% dying at home. The 2023 figures show a slight increase from 2022, which saw 510 deaths from unregulated drugs. Public Health Ontario and the Office of the Chief Coroner for Ontario confirmed 507 of those deaths, with three considered probable.

The peak of the pandemic in 2021 saw a record-breaking 591 confirmed drug toxicity deaths in Toronto. The city's Medical Officer of Health described the ongoing drug toxicity epidemic as a devastating human tragedy that necessitates a compassionate response. Toronto’s unregulated drug supply has become increasingly toxic, contaminated with unexpected and dangerous substances.

Toronto Public Health has issued four drug alerts this year to inform drug users, harm reduction organizations, and public health units about potent toxic substances in the unregulated drug supply and rising suspected overdoses.

Demand letter and medical record review offerOne key response to this crisis is the implementation of supervised consumption services (SCS), which provide clinical spaces where individuals can use drugs under the supervision of trained health professionals. Toronto currently has ten such sites.

Evidence indicates that SCSs save lives, connect people to social services, and serve as pathways to treatment. Toronto Public Health advocates for greater access to a comprehensive range of evidence-based healthcare services, including prevention, treatment, and harm reduction supports. The health unit remains committed to exploring collaborative solutions to this urgent public health issue.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Rules Roundup Warning Claims Preempted by Federal Law

Categories: Roundup

Bayer and its Monsanto subsidiary are seeking a pathway to challenge all Roundup cancer lawsuits before the U.S. Supreme Court, following a recent…

GSK Wins as Florida Court Rejects Zantac-Cancer Testimony

Categories: Zantac

GlaxoSmithKline (GSK) is seeking the dismissal of a Zantac lawsuit in Florida, following a favorable ruling by the state court judge to…

Avon Files for Bankruptcy Amid Talc Lawsuit Liabilities

Categories: Talcum

After being hit with a $24.4 million verdict in a talcum powder mesothelioma lawsuit, Avon Products, Inc. has declared bankruptcy, citing the…

Free Trials of Demand Letters & Medical Record Review     
+ Get A 10% Discount On Your First Billing.